Data / Medical devices / United States / Ascensia Diabetes Care US Inc.
Ascensia Diabetes Care US Inc.: FDA-registered device maker in Valhalla, NY, United States, 24 510(k) clearances and 2 PMA approvals
Ascensia Diabetes Care US Inc. is registered with the FDA (registration 1810909) in Valhalla, NY, United States. It lists 10 device types. The FDA files 24 510(k) clearances and 2 PMA approvals under its listings, the newest dated August 27, 2026. 3 recall events name it as the recalling firm. Registered through 2027. FDA data exported November 3, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 1810909
- Address
- 100 Summit Lake Drive, Valhalla, NY, United States, 10595
- Owner or operator
- Ascensia Diabetes Care Holdings AG (10050965)
- Roles
- Complaint file establishment, Specification developer
- First device listed
- January 21, 2016
- Registered through
- 2027
- Brand names listed
- CONTOUR NEXT, CONTOUR NEXT EZ, CONTOUR NEXT LINK, CONTOUR NEXT LINK 2.4, CONTOUR NEXT ONE, CONTOUR PLUS, CONTOUR PLUS LINK, CONTOUR PLUS LINK 2.4 and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| August 27, 2026 | K260545 | CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System; CONTOUR® NEXT ONE Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care | accessdata.fda.gov |
| August 27, 2024 | K241787 | CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care U.S., Inc. | accessdata.fda.gov |
| August 15, 2024 | K241810 | MICROLET®NEXT Lancet | QRK | Substantially Equivalent | Ascensia Diabetes Care U.S., Inc. | accessdata.fda.gov |
| February 23, 2024 | K231679 | CONTOUR® PLUS BLUE Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care | accessdata.fda.gov |
| November 18, 2022 | K223293 | CONTOUR® NEXT GEN Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care U.S., Inc. | accessdata.fda.gov |
| June 3, 2022 | K220633 | MICROLET NEXT lancing device, MICROLET Lancet | QRL | Substantially Equivalent | Ascensia Diabetes Care U.S., Inc. | accessdata.fda.gov |
| December 23, 2021 | K193407 | Contour® next GEN Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care | accessdata.fda.gov |
| August 11, 2021 | K210687 | CONTOUR® NEXT ONE Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care | accessdata.fda.gov |
| November 8, 2019 | K191286 | CONTOUR® NEXT Blood Glucose Monitoring System, CONTOUR® NEXT USB Blood Glucose Monitoring System, CONTOUR® NEXT ONE Blood Glucose Monitoring System, CONTOUR® NEXT EZ Blood Glucose Monitoring System, CONTOUR® NEXT LINK Wireless Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care | accessdata.fda.gov |
| January 12, 2017 | K162336 | Contour Next EZ Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care U.S., Inc. | accessdata.fda.gov |
| November 17, 2016 | K160682 | CONTOUR NEXT ONE Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care | accessdata.fda.gov |
| June 24, 2016 | K160430 | Contour Next Link Wireless Blood Glucose Monitoring System, Contour Next Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care U.S., Inc. | accessdata.fda.gov |
| September 23, 2015 | K151742 | Contour Next Control Solution | JJX | Substantially Equivalent | Bayer Healthcare | accessdata.fda.gov |
| June 23, 2014 | K130265 | CONTOUR NEXT EZ BLOOD GLUCOSE METER | NBW | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| September 26, 2013 | K122370 | CONTOUR NEXT LINK WIRELESS BLOOD GLUCOSE MONITOR | NBW | Substantially Equivalent | Bayer Healthcare | accessdata.fda.gov |
| July 26, 2012 | K121190 | CONTOUR NEXT BLOOD GLUCOSE METER | LFR | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| June 28, 2012 | K121087 | CONTOUR NEXT USB BLOOD GLUCOSE MONITORING SYSTEM | NBW | Substantially Equivalent | Bayer Healthcare | accessdata.fda.gov |
| March 28, 2012 | K110894 | CONTOUR NEXT LINK WIRELESS BLOOD GLUCOSE METER | LFR | Substantially Equivalent | Bayer Healthcare | accessdata.fda.gov |
| March 6, 2012 | K111268 | CONTOUR (R) NEXT BLOOD GLUCOSE MONITORING SYSTEM | LFR | Substantially Equivalent | Bayer Healthcare | accessdata.fda.gov |
| December 4, 2009 | K090628 | DIDGET BLOOD GLUCOSE METER, MODEL 6181; CONTOUR BLOOD GLUCOSE TEST STRIPS, MODEL 7080 | NBW | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| August 26, 2009 | K091820 | CONTOUR USB BLOOD GLUCOSE METER, GLUCOSE TEST STRIPS; GLUCOFACTS DELUX DIABETES MANAGEMENT SYSTEM | NBW | Substantially Equivalent | Bayer Healthcare | accessdata.fda.gov |
| September 11, 2006 | K062058 | ASCENSIA CONTOUR BLOOD GLUCOSE METER, MODEL 7151; REAGENT STRIP, MODEL 7080 | NBW | Substantially Equivalent | Bayer Healthcare | accessdata.fda.gov |
| September 8, 1983 | K831600 | DIASTIX REAGENT STRIPS FOR URINALYSIS | JIL | Substantially Equivalent | Miles Laboratories, Inc. | accessdata.fda.gov |
| July 8, 1980 | K801270 | TEST FOR KETONE IN URINE(ACETOACETIC AC | JIN | Substantially Equivalent | Miles Laboratories, Inc. | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| September 28, 2016 | P160017 | MiniMed 670G System | OZP | 126 | September 29, 2026 | accessdata.fda.gov |
| August 10, 2016 | P150001 | MINIMED 630G SYSTEM WITH SMARTGUARD(TM) | OZO | 100 | July 21, 2026 | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| May 19, 2023 | 92536 | Class II | Ongoing | Contour next GEN Blood Glucose Monitoring System | Ascensia Diabetes Care has determined through customer complaints that 580 of 2900 meters from lot number DM01T033P are reconfigured from mg/dL to mmol/L. Among them, 579 meters distributed in the United States were packaged into the meter kit and had incorrect factory-set unit of measure where the meters display glucose results in mmol/L rather than mg/dL. | accessdata.fda.gov |
| March 12, 2004 | 29444 | Not yet classified | Terminated | Clinitek 50 Urine Chemistry Analyzer; Product codes 6509C, 6513K, 6514C, 6515C, 6516F and 6518C. [The different product codes are for the various countries where the product is distributed). | Some units may only have had 1 read head screw installed instead of the three required by the firm's specifications. | accessdata.fda.gov |
| June 19, 2003 | 26312 | Not yet classified | Terminated | Clinitek 50 Urine Chemistry Analyzer; Product codes 6509C, 6513K, 6514C, 6515C, 6516F and 6518C. [The different product codes are for the various countries where the product is distributed.] | Analyzer will produce erroneous results due to missing grounding strap. | accessdata.fda.gov |
Compare with other makers
- All makers of System, Test, Blood Glucose, Over The Counter
- All makers of Single (Specified) Analyte Controls (Assayed And Unassayed)
- All makers of Glucose Dehydrogenase, Glucose
- All makers of Automated Insulin Dosing Device System, Single Hormonal Control
- All makers of Method, Enzymatic, Glucose (Urinary, Non-Quantitative)
- All makers of Automated Insulin Dosing , Threshold Suspend
Updated September 29, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.